Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality

Objective: TAVI is more frequently used to treat aortic stenosis with the mandate to have a low as possible rate of adverse events. We present our 30-day outcomes and one-year mortality and examine the factors associated with them. Methods: A prospective evaluation was performed of all patients who...

詳細記述

書誌詳細

出版年:	Hellenic Journal of Cardiology
主要な著者:	Christos Eftychiou, Nicolaos Eteocleous, Ioannis Zittis, Krikor Simamonian, Antonis Ioannou, Pantelitsa Loukaidou, Aliki Ntaka, Aris Hadjigregoriou, Vasilis Vasiliades, Maria Adamou, Eleni Constantinou, Panayiotis Avraamides
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2021-01-01
主題:	Transcatheter Aortic Valve Implantation TAVI outcomes TAVI survival TAVI MACE
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S1109966620302013